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Abstract Tau phosphorylation plays a crucial role in micro-
tubule stabilization and in Alzheimer’s disease. To characterize
the molecular mechanisms of tau binding on microtubules, we
synthesized the peptide R1 (QTAPVPMPDLKNVKSKIGST-
ENLKHQPGGGKVQI), reproducing the ¢rst tau microtubule
binding motif. We thermodynamically characterized the molec-
ular mechanism of tubulin assembly with R1 in vitro, and mea-
sured, for the ¢rst time, the binding parameters of R1 on both
growing and taxol-stabilized microtubules. In addition, we ob-
tained similar binding parameters with R1 phosphorylated on
Ser262. These data suggest that the consequences of Ser262
phosphorylation on tau binding to microtubules and on tubulin
assembly are due to large intramolecular rearrangements of the
tau protein. 4 2002 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Microtubule functions are regulated by microtubule-associ-
ated proteins (MAPs) such as tau or Map2. Tau is the most
studied because of its implication in Alzheimer’s disease [1,2]
as the main constituent of paired helical ¢laments (PHFs).
The C-terminal domain of tau proteins bears three to four
homologous 31/32 amino acid repeats (R1, R2, R3, R4) [1],
which constitute the microtubule binding domains, some of
which can bind to free tubulin [3] or to microtubule-incorpo-
rated tubulin [4,5] and promote tubulin assembly by them-
selves [6,7]. Repeat R1 binds more e⁄ciently [8] and induces
tubulin polymerization with a greater capacity [6]. Further-
more, this domain is believed to play a crucial role in tau
processes, being the target of speci¢c phosphorylations. In-
deed, phosphorylation appears to be the most critical step
in the biological and pathological processes implicating tau.
Many microtubule^MAP interaction studies have been car-
ried out using taxol-stabilized microtubules and di¡erent con-
structs or peptides corresponding to the repeat domains of tau
or Map2c [9]. Of all the described tau phosphorylation sites
[10], Ser262 is the only site in the ¢rst repeat domain R1.
Some discrepancy exists in the literature concerning the role
of this particular phosphorylation site. One study showed that
phosphorylation of Ser262 was not su⁄cient to eliminate the
binding of tau to microtubules [11], whereas a second one
showed that Ser262 phosphorylation abolished tau binding
to microtubules regardless of the phosphorylation state of
£anking domains [12]. More recently, the involvement of
Ser262 phosphorylation for inhibition of tau binding was
stressed again [13].
To clearly answer the question of R1 and Ser262 involve-
ment in tau binding to microtubules we synthesized peptide
R1, corresponding to the whole ¢rst tau repeat and its phos-
phorylated counterpart on Ser262, R1p. We ¢rst characterized
the in£uence of R1 on the molecular mechanism of tubulin
assembly, determining the thermodynamic parameters of the
process and the Mg2þ intake with and without R1. From this
point, we quantitatively studied R1 interaction with microtu-
bules in vitro. We measured the binding parameters of R1 on
growing microtubules, by extrapolation of the polymerization
curves, as well as on taxol-stabilized microtubules, by co-sed-
imentation assay. Last, to investigate the direct consequence
of phosphorylation on R1, we carried out the same quantita-
tive binding study with R1p. The data support the notion of
an intramolecular conformational change upon tau binding to
microtubules and led us to speculate on the mechanisms by
which phosphorylation of tau, by detaching it from the micro-
tubules, might lead to formation of PHFs in Alzheimer’s dis-
ease.
2. Materials and methods
2.1. Tubulin puri¢cation
Tubulin was puri¢ed from pig brains as previously described in [14].
Protein concentrations were determined spectrophotometrically with
an extinction coe⁄cient of O275 nm = 1.09 l g31 cm31 in 6 M guanidine
hydrochloride [14].
2.2. Peptide synthesis
R1 and R1p peptides were synthesized in Fmoc solid phase syn-
thesis [15] with HMP (4-hydroxymethyl^phenoxymethyl copoly-
styrene^1% divinylbenzene) preloaded resin (0.5^0.65 mmol) (Per-
kin-Elmer, Applied Biosystems Inc.). Peptides were deprotected
and released from the resin by tri£uoroacetic acid treatment. Peptide
R1 (QTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQI) corre-
sponds to amino acids 244^277 of the human tau [1]. R1p is the
same sequence with a phosphorylated residue on Ser262. Peptide pu-
rity was assessed by amino acid composition and high-performance
liquid chromatography (HPLC).
2.3. Tubulin assembly and co-sedimentation assay
Tubulin assembly was performed as described previously [16]. In
PEMG bu¡er (20 mM sodium phosphate bu¡er, 1 mM EGTA (ethyl-
ene glycol-bis(2-aminoethyl-ether)-N,N,NP,NP-tetraacetic acid), 10 mM
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MgCl2, 3.4 M glycerol, 0.1 mM GTP (guanosine triphosphate) pH
6.5) co-sedimentation assay was performed as described [7] with one
modi¢cation. We used a cushion of glycerol [8] during the centrifuga-
tion step to eliminate non-speci¢c binding. The supernatants were
then analyzed by HPLC (Pharmacia Aº KTA Puri¢er 900) using a
reverse phase column (Source 15RPC ST4.6/100) with a linear gra-
dient of 0^80% acetonitrile in 0.1% tri£uoroacetic acid. Using a cal-
ibration curve, we determined peptide concentration by absorbance at
210 nm. Experiments were done in triplicate.
2.4. Apparent thermodynamic parameters of R1-induced microtubule
assembly
Thermodynamic parameters can be obtained from the Van ’t Ho¡
plot of tubulin polymerization as described by Lee et al. [17] with the
equation
ln Kapp ¼ aþ b 1T
 
þ cðln TÞ ð1Þ
where Kapp is the apparent equilibrium constant for the growth reac-
tion (Kapp =Cr31, with Cr the critical concentration). The values of
free energy (vG0), enthalpy (vH0), entropy (vS0) and heat capacity
(vCp) are given by the following equations:
vG0app ¼ 3RT ln Kapp
vH0app ¼ RðcT3bÞ
vS0app ¼
ðvH0app3vG0appÞ
T
and
vCp ¼ RUc
2.5. Determination of the binding parameters of the peptide on growing
microtubules
Ligand binding parameters were determined using Timashe¡’s mod-
el [18]. The model can be expressed through a set of equations leading
to the ¢nal one:
Kgapp ¼ KgUð1þ KbUPÞ1=n ð2Þ
one molecule of P being added for each n-tubulin dimer incorporated
into microtubules. Kgapp is the experimentally determined growth con-
stant, which is the inverse of Cr in the presence of P, Kg is the inverse
of Cr without P, and Kb the binding constant of P to the microtubule.
Based on previous studies [19], we expected a low binding constant
and made the approximation (proven correct) that free P is very
similar to total P. All the ¢ttings were done using a graphics-¢tting
program (Sigmaplot 4.0, Jandel Scienti¢c). 3. Results
3.1. Thermodynamic parameters of tubulin assembly in the
presence of peptide R1
Tubulin assembly is greater in the presence of peptide R1,
but the overall shape of the polymerization is the same as that
followed by turbidimetry (Fig. 1). We veri¢ed by electronic
microscopy (data not shown) that the polymers were normal
microtubules. We determined that the minimum tubulin Cr
for polymerization (Cr= 4.0T 0.7 WM) is reached with 345
WM R1 (at 37‡C). It corresponds to about a two-fold
decrease, compared to polymerization without peptide
(Cr= 7.0T 0.5 WM) (data not shown). The e¡ects of temper-
ature on tubulin self-association were examined in PEMG
bu¡er for tubulin alone and in the presence of the peptide
(345 WM). As described for tubulin alone [17], a pronounced
curvature is observed in the Van ’t Ho¡ plot of tubulin
assembly with peptide (Fig. 2A). From Eq. 1 (see Section 2)
we deduced the apparent change in heat capacity vCp =
31495T 386 cal/(mol deg) of tubulin dimer added as well
as vG0app, vH
0
app, vS
0
app (see Fig. 2B) of this reaction. With
peptide R1 we obtained the same value of vCp (31493T 450
Fig. 1. Representative curves of polymerization followed by turbid-
ity. The tubulin assembly curve is given as a solid line, whereas tu-
bulin polymerization with 400 WM R1 is given as a dashed line. Tu-
bulin concentration is 13 WM. Polymerization is started by heating
the samples to 37‡C. At the time indicated by the arrow, the sam-
ples were cooled to 10‡C.
Fig. 2. Thermodynamics of tubulin assembly. A: Van ’t Ho¡ plot
of the microtubule growth reaction in PEMG bu¡er. The Crs used
to determine the Kapp were measured at temperatures ranging from
23 to 43‡C. The solid line is the theoretical curve obtained by ¢tting
a, b and c (see Section 2). B: Enthalpy and entropy contributions
to the apparent standard free energy change of elongation of tubu-
lin in PEMG bu¡er of tubulin alone (left panel), and of tubulin
with 345 WM R1 (right panel). The dots on the vG0app curve repre-
sent the experimental points from the Van ’t Ho¡ plot. All the oth-
er points (solid line) were calculated and extrapolated (see Section
2). Each point represents the average of several experiments with
di¡erent tubulin preparations.
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cal/(mol deg)) and very similar thermodynamic pro¢les (Fig.
2B), indicating that the overall thermodynamic parameters are
not signi¢cantly a¡ected. Last, to determine the Mg2þ intake
during the polymerization process, Mg2þ being an essential
cofactor in tubulin polymerization [20,21], we calculated the
Cr for di¡erent concentrations of Mg2þ, in the presence of a
¢xed concentration of R1 (345 WM). Using the Wyman plot
analysis described by Lee et al. [17], we found a slope of
1.1 T 0.2 (data not shown), which indicates a di¡erence in
preferential interaction of one additional Mg2þ per tubulin
molecule incorporated into microtubules, similar to the case
for tubulin alone.
All these results indicate that R1 favors polymerization
without disturbing the polymerization process, in contrast to
other stabilizing agents such as taxol, for which both poly-
merization thermodynamic parameters and Mg2þ ions incor-
porated are a¡ected [22].
3.2. Determination of the binding parameters of R1 and R1p on
growing microtubules by polymerization curve
extrapolation
Using a set of di¡erent polymerization curves for various
concentrations of R1 we plotted Kgapp as a function of
R1 concentration (Fig. 3A). Using Eq. 2 we found the a⁄n-
ity binding constant of the peptide for microtubules Kb =
(1.56T 0.67)U104 M31 and the number of dimers incorpo-
Fig. 3. Extrapolation of the polymerization curves leading to the binding parameters of tubulin assembly: (A) tubulin in the presence of various
concentrations of R1 and (B) in the presence of various concentrations of R1p. The solid line is the theoretical curve obtained by ¢tting n and
Kb (see Section 2). The points represent averages of multiple experiments.
Fig. 4. Microtubule binding activity of R1 and R1p. (A) and (C) are the saturation curves of R1 and R1p, respectively. (B) and (D) are the
corresponding Scatchard plots. The tubulin dimer concentration incorporated in microtubules was calculated by subtracting the amount of tu-
bulin that did not polymerize (Cr) from the total tubulin concentration used in the assay. Each point represents the average of several binding
experiments. In the Scatchard plots, axes are molar ratios.
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rated in microtubules per mol of peptide bound n=3.95T
0.78. With R1p (Fig. 3B) we obtained Kb = (3.28 T 2.95)
U104 M31 and n=4.49T 2.25. In both cases binding con-
stants and stoichiometry are similar; one peptide for about
four dimers was incorporated into a microtubule.
3.3. Direct measurement of the binding parameters of R1 and
R1p on taxol-stabilized microtubules
We also compared by a quantitative co-sedimentation assay
the microtubule a⁄nity of both peptides by directly measuring
their binding constants on preformed taxol-stabilized micro-
tubules. Fig. 4A,C shows the saturation curves of R1 and R1p
in the range of concentrations used (0^200 WM for R1 and 0^
350 WM for R1p). Scatchard plots (Fig. 4B,D) correspond to a
binding constant of Kb = (0.64 T 0.22)U104 M31 for R1 and
Kb = (0.51T 0.10)U104 M31 for R1p. These values are similar.
We found stoichiometries of nP=0.08T 0.04 and nP=0.10
T 0.02 per dimer of tubulin for R1 and R1p, respectively,
which corresponds to a stoichiometry of about one tau pep-
tide for every 10 dimers.
4. Discussion
Up to now, experiments had been conducted to test the
in£uence of phosphorylation on other repeat domains [23],
but no direct measurement had been made between the phos-
phorylated R1 domain and the entire tubulin in microtubules,
in which conformation change might occur. In our study on
Ser262 of R1 repeat, phosphorylation modi¢es neither the
apparent binding constant nor the stoichiometry of R1 do-
main binding on microtubules. These results clearly show that
phosphorylation on Ser262 of R1 repeat is not su⁄cient to
induce its detachment or to diminish tubulin assembly. Fur-
thermore, the relatively small di¡erence in binding constant
between the two protocols for R1 or R1p is in favor of a
binding site easily accessible on the lattice of the microtubule,
since the state of the microtubule, growing or stabilized,
makes no di¡erence. In both cases we ¢nd a constant in
good agreement with the one determined in di¡erent bu¡er
conditions (PIPES, EGTA, Mg2þ 1 mM) by Aizawa et al.
(Kb = 5550 M31) for non-phosphorylated peptide [7]. This is
a rather low apparent binding constant, 5000^10 000 M31,
about 1000 times lower than tau itself. Considering that the
summation of three to four repeat domains [8,24,25] is not
su⁄cient to explain such a large binding constant, and that
R1 has the strongest e¡ect on microtubules [6,8], R1 is prob-
ably involved in the ¢rst steps of the binding, but there must
be some conformational change in tau involving other do-
mains of the protein, which enhances its binding on micro-
tubules.
The di¡erences we found in the stoichiometry, 0.1^0.25 pep-
tide per tubulin dimer against 1.3 peptide per tubulin dimer
found by Aizawa et al. [7], may be explained by the size of the
peptide itself, 14 amino acids longer, but most of all by the
use of a glycerol cushion in our co-sedimentation assay, which
probably gets rid of non-speci¢c binding [8]. Nevertheless, it is
interesting to note that these surprisingly low stoichiometry
values, especially considering that tau has been reported to
bind both on K and L C-terminal parts of tubulin [26], are
close to the one found for the entire tau protein [27] or other
MAPs [28]. This would tend to rule out substoichiometry as
an argument for tau binding longitudinally along the proto-
¢lament versus a bridging of the microtubules. It merely
shows that steric hindrance is not responsible for the low
stoichiometry of the tau protein. Nevertheless, this substoi-
chiometric binding is su⁄cient to explain its stabilizing e¡ect
on the microtubule [29].
Phosphorylation of Ser262 clearly induces tau detachment
of the microtubule with a decrease in binding stoichiometry
and a destabilizing e¡ect [12,30]. In contrast, this phosphory-
Fig. 5. Schematic representation of conformational change and binding interaction of tau to microtubule: (a) is a regular tubulin dimer;
(b) represents the probable conformational change of tubulin due to peptide R1 binding; (c) shows a larger conformational change, correlated
to the 10-fold increase in assembly in the presence of the proline-rich region observed by Goode et al. [32] ; (d) shows a possible model of tau
binding to tubulin in which tau adopts a more complex ordered structure involving intramolecular interactions between the repeats and the
proline-rich region. Tau binding in turn guides the tubulin dimer into a stable, folded pro-microtubule conformation; (e) shows no di¡erence
compared to (b) as demonstrated in this paper; (f) and (g) hypothesize the lack of pro-microtubule e¡ect by the £anking domains when the
protein is phosphorylated on Ser262. Ser262 phosphorylation prevents the conformational change necessary for maximum assembly e⁄ciency.
The e¡ect observed is only due to the binding of R1 (case (b)). The isoforms of tubulin (K and L) were voluntarily omitted to insist on the
fact that the peptide probably binds both of them.
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lation on R1 does not. The structure of tau, when bound at
the microtubule surface, di¡ers from the structure of the pep-
tide itself. This result is again in favor of an intramolecular
conformational modi¢cation implicating other domains of tau
that would in£uence R1 binding e⁄ciency.
The £anking regions, which have been shown to play an
important part since their phosphorylation detaches the tau
protein or diminishes its a⁄nity [13,31], are good candidates
for these intramolecular interactions. Among these, the pro-
line-rich domain causes a 10-fold increase in the e⁄ciency of
peptide-induced microtubule assembly when joined to the
R1+R1R2 inter-repeat sequence [32]. Our data are also com-
patible with an interaction between the proline-rich domain
and repeat regions of tau. This model, summarized in Fig. 5,
would explain why phosphorylation has a dual e¡ect depend-
ing on the construct. With R1, no di¡erence is observed upon
phosphorylation, whereas on bigger constructs (with £anking
domains) and on the entire tau, phosphorylation on Ser262
prevents the conformational change necessary for better tubu-
lin assembly induction and favors detachment of tau from the
microtubule. Further phosphorylation on additional speci¢c
sites then leads to PHF formation [33]. Ser262 phosphoryla-
tion is thus a key step both in the physiological regulation of
microtubule assembly and in the pathological induction of
PHFs in Alzheimer’s disease, but in both cases it implicates
the £anking domains of tau.
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